Vivos Inc Stock Today
| RDGL Stock | USD 0.08 0.01 9.09% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Vivos is selling for 0.08 as of the 22nd of December 2024. This is a 9.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.068. Vivos has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of December 2024. Click here to learn more.
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. VIVOS INC operates under Medical Devices classification in the United States and is traded on OTC Exchange. The company has 359.89 M outstanding shares. More on Vivos Inc
Moving together with Vivos OTC Stock
Moving against Vivos OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Vivos OTC Stock Highlights
| President CEO, Director | Michael Korenko |
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Vivos Inc [RDGL] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vivos's market, we take the total number of its shares issued and multiply it by Vivos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vivos Inc conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 359.89 M outstanding shares.
Vivos Inc currently holds about 1.99 M in cash with (963.82 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Vivos Probability Of Bankruptcy
Ownership AllocationVivos Inc shows a total of 359.89 Million outstanding shares. Vivos Inc has 5.41 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Vivos Ownership Details
Vivos Inc Risk Profiles
| Mean Deviation | 3.91 | |||
| Standard Deviation | 5.4 | |||
| Variance | 29.17 | |||
| Risk Adjusted Performance | (0.12) |
Vivos Stock Against Markets
Picking the right benchmark for Vivos otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vivos otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vivos is critical whether you are bullish or bearish towards Vivos Inc at a given time. Please also check how Vivos' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vivos without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Vivos Corporate Management
Elected by the shareholders, the Vivos' board of directors comprises two types of representatives: Vivos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vivos. The board's role is to monitor Vivos' management team and ensure that shareholders' interests are well served. Vivos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vivos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | Chief Officer | Profile | |
| FuMin Su | Chief Officer | Profile | |
| PE MS | Chief Mang | Profile | |
| Carlton DDS | Independent Sec | Profile | |
| Dr BSc | Chief Officer | Profile |
Other Information on Investing in Vivos OTC Stock
Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.